Long-term outcome of using a covered stent to prevent restenosis in transjugular intrahepatic portosystemic shunt

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000181

Enrollment

Unknown

Registered

2008-10-20

Start date

2007-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal hypertension

Interventions

Control group:transjugular intrahepatic portosystemic shunt by using uncovered stent from rear service department of West China Hospital by invited public bidding.

Experimental group:transjugular intrahepatic portosystemic shunt using covered stent from rear service department of West China Hospital by invited public bidding

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients in hospital aged from 18 to 75; 2. At least a episode of variceal bleeding history; 3. Refractory ascites or Hepatic Hydrothorax; 4. Budd-Chiari Syndrome; 5. Participants attend the trial of their own free will and sign the informed consent form before treatment.

Exclusion criteria

Exclusion criteria: 1. Heart Failure; 2. Serve infection or blood poisoning; 3. Severe coagulation disorders; 4. Refractory hepatic encephalopathy.

Design outcomes

Primary

Measure	Time frame
Patency rates at 0.5,1 and 2 year after TIP;	—

Secondary

Measure	Time frame
recrudescence of ascites and hydrothorax;survival time;Child-Pugh classification;episodes of gastrointestinal bleeding;	—

Countries

China

Contacts

Public ContactChengwei Tang

cwtang@medmail.com.cn+86 028 81812275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026